A direct RT-qPCR approach to test large numbers of individuals for SARS-CoV-2 by Maricic, T. et al.
1 
 




Tomislav Maricic1*, Olaf Nickel2, Ayinuer Aximu-Petri1, Elena Essel1, Marie Gansauge1, 
Philipp Kanis1, Dominik Macak1, Stephan Riesenberg1, Lukas Bokelmann1, Hugo Zeberg1,3, 
Matthias Meyer1, Stephan Borte2,4,5 and Svante Pääbo1* 
 
 
1Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany; 
2Department of Laboratory Medicine, Hospital St. Georg, Leipzig, Germany; 
3Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden; 
4ImmunoDeficiencyCenter Leipzig (IDCL) at Hospital St. Georg Leipzig, Jeffrey Modell 
Diagnostic and Research Center for Primary Immunodeficiency Diseases, Leipzig, Germany; 
5Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska University 
Hospital Huddinge at Karolinska Institutet, Stockholm, Sweden. 
 
*Correspondence to:  
Tomislav Maricic, tomislav_maricic@eva.mpg.de, Max Planck Institute for Evolutionary 
Anthropology, Deutscher Platz 6, D-04103 Leipzig, Germany. 
Svante Pääbo, paabo@eva.mpg.de, Max Planck Institute for Evolutionary Anthropology, 





SARS-CoV-2 causes substantial morbidity and mortality in elderly and immunocompromised 
individuals, particularly in retirement homes, where transmission from asymptomatic staff and 
visitors may introduce the infection. Here we present a cheap and fast approach to detect SARS-
CoV-2 in single or pooled gargle lavages (“mouthwashes”). With this approach, we test all staff 
at a nursing home daily over a period of three weeks in order to reduce the risk that the infection 
penetrates the facility. This or similar approaches could be implemented to protect hospitals, 
nursing homes and other institutions in this and future viral epidemics.  
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The COVID-19 pandemic has led to substantial morbidity and mortality in elderly and 
immunocompromised individuals, particularly in long-term care facilities (McMichael et al, 
2020). Up to half of the fatalities in Europe have been observed in retirement homes (WHO, 
2020), where advanced age and chronic underlying health conditions seem to predispose  
residents (Vishnevetsky & Levy, 2020). Therefore, it is necessary to prevent that infected 
personnel and visitors enter institutions where vulnerable individuals live.  
 However, infected individuals are often asymptomatic (Gandhi et al, 2020; Oran & 
Topol, 2020), resulting in a considerable rate of presymptomatic transmission of SARS-CoV-
2. Furthermore, the viral load, and presumably the ability to transmit the infection, is highest 
at the time of symptom onset or just before (He et al, 2020). To prevent the spread of infection 
to institutions, one would therefore ideally test all individuals entering the facilities every time 
they do so. However, most commercially available viral test systems are too expensive and too 
laborious for such a strategy. In addition, swab kits and RNA extraction kits may run out during 
a pandemic (Baird, 2020). 
Here, we present a safe, cheap and fast PCR-based approach to detect individuals with 
high levels of SARS-CoV-2 without the need for nasopharyngeal swabs or RNA extraction. We 
performed daily tests of all staff and residents of a local nursing home previously affected by 
COVID-19. We suggest that this approach could easily be scaled-up to test all staff members 





Nasopharyngeal swabs are commonly used to collect samples for SARS-CoV-2 testing. 
However, this exposes a person taking the sample to risk of infection when manipulating swabs 
in the nose and pharynx of potentially infectious individuals. We (in preparation) and others 
(Malecki et al, 2020; Saito et al, 2020) have shown that liquid washes of the oral cavity (‘gargle 
lavage’) can be used as a more practical, safe yet efficient alternative to nasopharyngeal swabs. 
This is particularly attractive for frequent sampling of asymptomatic individuals, as gargle 
lavages are not associated with any discomfort and can be applied to most individuals in a 
broad age range. We therefore focused our efforts on making such gargle lavages, commonly 
referred to as ‘mouthwashes’, amenable to detection of SARS-CoV-2 without isolation of viral 
RNA.  
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Figure 1. RT-qPCR of 10 previously SARS-CoV-2 positive (P) and 10 previously SARS-CoV-
2 negative (N) mouthwashes. RNA was either extracted from 200 l of mouthwashes (black 
bars) or 1 l of the mouthwashes was added directly to the RT-qPCR reaction mix without prior 
extraction (colored bars). Dashes at N/A indicate no amplification of the viral target.  
 
 To this end, we investigated mouthwashes from 10 individuals who previously tested 
positive for SARS-CoV-2 and 10 individuals who did not. From each mouthwash, we used 200 
microliter (l) for RNA extraction in the MagNA Pure 24 System (Roche, Basel, Switzerland) 
and 10 l of the resultant 50 l RNA extract for reverse transcriptase (RT) quantitative 
polymerase chain reaction (qPCR) detection of SARS-CoV-2 using the LightCycler Multiplex 
RNA Master kit from Roche. Nine of the individuals, who on a previous occasion had tested 
positive, were positive in this occasion whereas none of the previously negative individuals 
were positive.  
We then tested 1 l of mouthwash from each of the 20 individuals using two RT-qPCR 
kits advertised to allow direct detection of SARS-CoV-2 from nasopharyngeal swabs: Luna 
Universal Probe (NEB, Ipswich, USA) and PrimeDirect (Takara, Kyoto, Japan) as well as 
another kit, SuperScript III with Platinum Taq (Invitrogen, Waltham, USA). The previously 
negative mouthwashes were negative in all cases. Among the previously positive 
mouthwashes, five were positive using the NEB kit whereas one and two were positive using 
the Takara and Invitrogen kits, respectively (Fig. 1). Although we expect the tests to be 
somewhat stochastic at high cycle threshold (Ct) values (the higher the Ct value, the lower the 
number of viral targets), the NEB Luna kit performs better with mouthwashes than the other 
two kits. 
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Figure 2. Roche RNA extraction/RT-qPCR and NEB Luna RT-qPCR of seven reference 
samples. Dots at N/A show no amplification of the viral target. 
 
The Roche RNA extraction and qRT-PCR combination as well as the NEB kit were 
validated against a set of 7 reference samples distributed by “INSTAND” reference institution 
of the German Medical Association (Duesseldorf, Germany). These samples contain different 
concentrations of a heat-inactivated SARS-CoV-2 virus (sample 59, 61, 63 and 64), another 
coronavirus genus (sample 60 HCoV OC43, sample 65 HCoV 229E) or no virus (sample 62, 
supernatant of a non-infected cell culture). Fig. 2 shows that both approaches detected the 
SARS-CoV-2-containing samples and showed not amplification for samples not containing 
SARS-CoV-2.  
  
Figure 3. (A) Roche RNA extraction/RT-qPCR and NEB Luna RT-qPCR for SARS-CoV-2 
detection in 62 mouthwash samples from hospital patients. The NEB method detects the virus 
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when Ct of the Roche method is less than 29 (blue box). Dots at N/A show no amplification of 
the viral target. (B) Correlation of Ct values between direct NEB assays and RNA extraction 
followed by Roche assays for mouthwash samples positive with both methods. 
 
  To systematically investigate how the NEB Luna assay performs compared to RNA 
extraction followed by the Roche assay for mouthwash samples, we investigated 62 gargle 
lavages from patients that were either negative or presented with various viral loads based on 
previous investigations. Fig. 3A shows that although the direct assay requires about four 
additional qPCR cycles on average to detect the virus, the direct assay performs well in samples 
where the RNA extraction-based assay detects viruses at a Ct values of ~29 or lower, i.e. for 
samples that contain high viral genome counts. Among the samples positive in both methods, 
i.e. samples with Ct values of ~40 or lower for the NEB assay, the results of the two methods 
correlate reasonably well (Fig. 3B; Pearson’s r=0.86). Notably, the extraction-free NEB assay 
uses 20-fold less mouthwash per assay than the Roche assay (2 l vs. 40 l), corresponding 
approximately to the average difference of the observed four PCR cycles (24=16). Thus, the 
NEB assay per se is of similar sensitivity as RNA extraction followed by the Roche assay. 
 The use of mouthwashes and direct RT-qPCR assays allow testing of large numbers of 
individuals. We therefore applied it to the residents and personnel of the retirement home 
Emmaus in Leipzig, Germany. This facility has 77 full-time residents and 88 nursing, cleaning 
and catering staff. In April 2020, two COVID-19 cases occurred among the residents and staff.  
After appropriate informed consent, all staff working at the facility delivered a daily 
gargle lavage sample at the beginning or end of their working shifts. These were collected 
between 3 p.m. and 4 p.m. every day for 21 days and transported to the laboratory at room 
temperature. On weekends and holidays, the numbers of samples varied between 22 and 26 
and during weekdays between 35 and 50.  
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Figure 4. Daily testing of personnel of a nursing home with or without pooling of 
mouthwashes. Red color indicate a SARS-CoV-2 positive individual/sample. 
 
We applied two testing schemes to minimize the risk that the virus could affect residents 
again. In the first scheme, the samples were tested individually using the direct RT-qPCR 
protocol and the results were evaluated and reported back to the facility by 7 p.m. To detect 
any inhibition that the mouthwash samples may introduce into the RT-qPCR reactions, we 
added a synthesized control RNA that was quantified in parallel with SARS-CoV-2 by a probe 
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carrying a different fluorophore (Cy5) from the SARS-CoV-2 probe (FAM). For three of the 
756 mouthwashes, significant inhibition was detected (Suppl. Table 1). These samples were 
further tested using half the mouthwash volume, which lowered the inhibition to acceptable 
levels (Suppl. Table 1). Nine samples were putatively positive at Ct values of 36 and higher. 
These were further tested by agarose electrophoresis of the PCR product and further RT-qPCR 
tests. In all cases, the PCR products were of unexpected sizes and renewed testing was negative 
(Suppl. Table 1). In summary, all 756 individual mouthwashes we tested in 21 days were 
negative. 
 In a second scheme (Fig. 4), we explored if the daily testing could be scaled up by 
pooling samples. To this end, we first investigated if single positive samples with Ct values 
between 19 and 31could be detected in pools of 26 samples. From these pools, 2 µl were used 
for the direct NEB assay while 200 µl were used for the RNA extraction and the Roche assay. 
Fig. 5 shows that in all six cases, the pools containing a mouthwash from a single infected 
individual were detected by the extraction-free NEB assay as well as by the standard Roche 
assays after RNA extraction.  
 
 
Figure 5. Tests of seven pools of 26 mouthwash samples, which in six cases contain one 
positive sample. Dashes at N/A show no amplification of the viral target.  
 
We combined the samples from the Emmaus retirement home from each day into two 
pools of approximately equally many individuals and tested these pools (Fig. 4). In agreement 
with the individual test, none of the pools were positive. Ct values for the positive RNA control 
was ~27 when no mouthwash was added and ~28 or less for the pools, indicating that the 
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inhibitory component seen in rare individual mouthwash samples becomes diluted and do not 
inhibit the reaction as much in a pool. 
 
Discussion 
During the current SARS-CoV-2 epidemic morbidity and mortality primarily affect old or 
immunocompromised individuals. Thus, it is important to protect facilities where such 
individuals live from infections transmitted by staff or visitors. This applies not only to SARS-
CoV-2 but also to other airborne communicable diseases such as influenza, RSV and 
adenovirus, which result in high rates of disease and death among vulnerable individuals.  
 To protect such individuals, it is necessary to reduce the risk of transmission from 
asymptomatic carriers. This is particularly the case for SARS-CoV-2, as many carriers are 
asymptomatic (Oran & Topol, 2020), and  their infectiousness may be highest before the onset 
of symptoms (He et al, 2020; Wolfel et al, 2020). It is therefore desirable to test asymptomatic 
individuals that come into contact with vulnerable individuals as frequently as possible. The 
protocol described here enables large-scale high-throughput screening at a reagent costs of 
about 2-4 Euros per sample (in 2020 NEB Luna kit cost ~0.6 Euros per sample and 
primer/probes cost 1.5-3.5 Euros depending on the provider).  
 Three factors make this approach suitable for implementation on a large scale. Firstly, 
gargle washes rather than nasopharyngeal swabs have the advantage that they can be collected 
by the individuals themselves and do not expose any personnel performing sampling to risk of 
infection. They are also not associated with any discomfort for the person being tested so that 
they can easily be performed on a daily basis. Secondly, since the protocol does not require 
isolation of RNA, it reduces the need for equipment, reagents, labor, time and money allowing 
larger numbers of tests to be performed. Thirdly, pooling of samples allows large numbers of 
individuals to be tested. A practical approach might be to divide the staff at each institution into 
two pools to allow one group to return to work even if the other group would turn out to contain 
one or more positive individuals. Using this approach, about 45 institutions of the size of the 
retirement home tested here could be analyzed on a single, 96-well microtiter plate in about an 
hour and half (~3,700 individuals, ~300 Euros total reagent cost). 
In principle, it would be preferable to test staff members before starting their work shifts 
and come into contact with residents. However, including transport and evaluation, between 
two and five hours are needed before results can be reported back to the facility. Thus, it is 
more practical to perform the tests in the evening. If one individual, or one pool of samples, is 
found to be positive, that individual or group of individuals can then be prevented from working 
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the next day, and, in the case of pooled samples, be individually tested. In the future, other 
methods such as reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) 
(Yu et al, 2020) may be developed to a point where they can performed reliably locally at 
facilities at risk such that staff can be tested before they start their daily work. 
 The RNA isolation-free assays are slightly less sensitive than the standard assay due to 
the smaller volume of mouthwash that can be used in the assay. However, there is evidence that 
only individuals with a high viral load (a Cq value of 30 or lower) are likely to transmit the 
infection (NCID, 2020; Wolfel et al, 2020; Zhou et al, 2020). Thus, we suggest that the 
advantage of daily testing greatly outweighs the lower sensitivity in the low-copy range. 
 We note that if a rapid and inexpensive testing scheme like the one presented here is 
implemented, personal visits to individuals at risk could be allowed with large social benefits. 
For example, if visitors were tested in the morning they could, if negative, visit in the afternoon. 
We furthermore note that simplified testing could also be applied to asymptomatic travelers to 
slow the spread of infections - while still allowing global travel. Finally, we can foresee that 
with daily testing of staff members and visitors of retirement homes, hospitals, prisons and 
critical infrastructure, society may be able to sustain function with minimal restrictions in cases 
where a virus poses little threat to young and healthy individuals as is the case for the current 
SARS-CoV-2 and seasonal influenza outbreaks.  
Future evolution of SARS-CoV-2 or other viruses could result in strains causing an 
increased major morbidity also in the general population. Obviously, large-scale applications 
of simplified tests of pooled samples as described here are likely to be extremely valuable to 
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Materials and Methods 
All individuals included in this study were asked for their voluntary assistance to participate. 
Each individual gave written informed consent before entry into the study. The study was 
approved by the Ethics Committee of the Saxonian medical chamber (EK-allg-37/10-1). All 
procedures utilized in this study are in agreement with the 1975 Declaration of Helsinki. 
 
Gargle lavages (‘mouthwashes’) 
For mouthwashes, 10 mL of sterile water was pre-filled into sterile scaled urine cups. The 
individuals to be tested took the full volume of water into the mouth and gargled for 10 seconds. 
Subsequently, the mouthwash was spitted back into the cup and firmly closed with a watertight 
lid and stored at room temperature for up to 4-8 hours.We also analyzed anonymized leftover 
material from hospitalized COVID-19 patients. In these cases, mouthwashes had been stored 
frozen below -80°C for 1-2 months. 
 
Primers and probes for RT-qPCR 
All primers, probes and controls were from Tib-Molbiol (Berlin, Germany). For SARS-CoV-2 
detection, the E-gene was detected with a FAM probe (Cat.-No. 53-0776-96). For inhibition 
tests, EAV RNA Extraction Control 660 with Cy5 probe (Cat.-No. 66-0909-96) was used. 
 
Roche RNA extraction and RT-qPCR 
Individual mouthwashes were vortexed and 200 µl were used for RNA extraction with the 
MagNA Pure 24 System from Roche based on the manufacturer’s protocol. RNA was eluted in 
50 µl of which 10 µl was used in the RT-qPCR LightCycler Multiplex RNA Master kit with 
4.9 µl water, 0.5 µl E-gene primer and probe reagent mix, 0.5 µl EAV control primer and probe 
reagent mix, 4 µl RT-PCR reaction mix and 0.1 µl RT-enzyme solution. The RT reaction was 
performed at 55°C for 5 minutes. qPCR included a denaturation step at 95°C for 5 minutes, 
followed by 45 cycles with 5 seconds at 95°C, 15 second at 60°C and 15 seconds at 72°C. RT-
qPCR reaction was performed on a and analyzed with Roche LightCycler 480 Software.       
 
Direct RT-qPCR 
Mouthwashes were vortexed and either 1 or 2 µl were added into a reaction tube containing 
pre-assembled reagents. RT-qPCR reaction was run on BioRad CFX96 Real-Time system and 
results analyzed with Bio-Rad CFX Manager software where the Ct determination mode was 
set to “regression”.  
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Takara PrimeDirect Probe One-step RT-qPCR  
Twenty five µl reactions contained: 12.5 µl prime direct mix, 0.5 µl E-gene primer and probe 
reagent mix, 1 µl mouthwash and 11 µl water. The reaction was incubated at 90ºC for 3 minutes, 
60 ºC for 5 minutes followed by 50 cycles of 95 ºC for 5 seconds and 55 ºC for 30 seconds. 
 
Invitrogen SuperScript III with Platinum Taq One-Step RT-qPCR 
Twenty five µl reaction contained:  12.5 µl rxn mix, 0.5 µl E-gene primer and probe reagent 
mix, 0.4 µl MgSO4, 1 µl enzyme mix, 1 µl mouthwash and 9.6 µl water. The reaction was 
incubated at 60 ºC for 5 minutes, 55 ºC for 5 minutes, 95 ºC for 2 minutes followed by 50 
cycles of 94 ºC for 5 seconds, 60 ºC for 30 seconds and 68 ºC for 10 seconds. 
 
NEB Luna Universal Probe One-Step RE-qPCR kit  
Twenty five µl reaction contained: 12.5 µl Reaction MasterMix, 1.25 µl EnzymeMix, 0.5 µl E-
gene primer and probe reagent mix, 0.5 µl EAV control primer and probe reagent mix, 0.5 µl 
EAV control (pellet eluted in 1,200 µl TE buffer), 1-2 µl mouthwash, and 8.75-9.75 µl water. 
For Fig.1, 1 µl of mouthwash was used, for later experiments 2 µl to allow for more accurate 
pipetting. Mastermix can be stored in the fridge up to a week. RT-qPCR program for the NEB 
reaction was: 55 ºC for 4 minutes, 60 ºC for 4 minutes, 55 ºC for 2 minutes, 95 ºC for 1 minute 
followed by 50 cycles of 95 ºC for 10 seconds and 60 ºC for 30 seconds. 
 
Acknowledgements 
The authors thank the management of Diakonische Dienste Leipzig, the personnel and residents 
of Altenpflegeheim Emmaus in Leipzig, Germany, for their cooperation. Furthermore, we 
recognize the efforts and helpful instructions contributed by Nils Lahl from the public health 
department of the City of Leipzig. We particularly thank Jeannine Dulz, Katrin Grabietz, 
Jeannette Hofmann, Michelle Karius, Sandra Reinhardt, Kerstin Rolle, Katharina Wald, 
Kristina Winter for assisting and performing reference and confirmatory testing at the 
Department of Laboratory Medicine at Hospital St Georg Leipzig. Funding was provided by 




 . CC-BY-NC-ND 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted June 26, 2020. .https://doi.org/10.1101/2020.06.24.20139501doi: medRxiv preprint 
12 
 
Baird, P. R. (2020) Why Widespread Coronavirus Testing Isn’t Coming Anytime Soon, The 
New Yorker2020. 
Gandhi, M., Yokoe, D. S. & Havlir, D. V. (2020) Asymptomatic Transmission, the Achilles' 
Heel of Current Strategies to Control Covid-19. N Engl J Med, 382(22), 2158-2160. 
He, X., Lau, E. H. Y., Wu, P., Deng, X., Wang, J., Hao, X., Lau, Y. C., Wong, J. Y., Guan, Y., 
Tan, X., Mo, X., Chen, Y., Liao, B., Chen, W., Hu, F., Zhang, Q., Zhong, M., Wu, Y., Zhao, L., 
Zhang, F., Cowling, B. J., Li, F. & Leung, G. M. (2020) Temporal dynamics in viral shedding 
and transmissibility of COVID-19. Nat Med, 26(5), 672-675. 
Malecki, M., Lusebrink, J., Teves, S. & Wendel, A. F. (2020) Pharynx gargle samples are 
suitable for SARS-CoV-2 diagnostic use and save personal protective equipment and swabs. 
Infect Control Hosp Epidemiol, 1-2. 
McMichael, T. M., Currie, D. W., Clark, S., Pogosjans, S., Kay, M., Schwartz, N. G., Lewis, 
J., Baer, A., Kawakami, V., Lukoff, M. D., Ferro, J., Brostrom-Smith, C., Rea, T. D., Sayre, M. 
R., Riedo, F. X., Russell, D., Hiatt, B., Montgomery, P., Rao, A. K., Chow, E. J., Tobolowsky, 
F., Hughes, M. J., Bardossy, A. C., Oakley, L. P., Jacobs, J. R., Stone, N. D., Reddy, S. C., 
Jernigan, J. A., Honein, M. A., Clark, T. A., Duchin, J. S., Public, H.-S., King County, E. & 
Team, C. C.-I. (2020) Epidemiology of Covid-19 in a Long-Term Care Facility in King County, 
Washington. N Engl J Med, 382(21), 2005-2011. 
NCID (2020) Position Statement from the National Centre for Infectious Diseases 
and the Chapter of Infectious Disease Physicians, Academy of Medicine, Singapore – 23 May 
2020, 23 May. 
Oran, D. P. & Topol, E. J. (2020) Prevalence of Asymptomatic SARS-CoV-2 Infection: A 
Narrative Review. Ann Intern Med. 
Saito, M., Adachi, E., Yamayoshi, S., Koga, M., Iwatsuki-Horimoto, K., Kawaoka, Y. & 
Yotsuyanagi, H. (2020) Gargle lavage as a safe and sensitive alternative to swab samples to 
diagnose COVID-19: a case report in Japan. Clin Infect Dis. 
Vishnevetsky, A. & Levy, M. (2020) Rethinking high-risk groups in COVID-19. Mult Scler 
Relat Disord, 42, 102139. 
WHO (2020) Statement – Invest in the overlooked and unsung: build sustainable people-
centred long-term care in the wake of COVID-19, 23.4.2020. 
Wolfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Muller, M. A., Niemeyer, 
D., Jones, T. C., Vollmar, P., Rothe, C., Hoelscher, M., Bleicker, T., Brunink, S., Schneider, J., 
Ehmann, R., Zwirglmaier, K., Drosten, C. & Wendtner, C. (2020) Virological assessment of 
hospitalized patients with COVID-2019. Nature, 581(7809), 465-469. 
Yu, L., Wu, S., Hao, X., Dong, X., Mao, L., Pelechano, V., Chen, W. H. & Yin, X. (2020) Rapid 
detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal 
amplification (RT-LAMP) diagnostic platform. Clin Chem. 
Zhou, J., Otter, J., Price, J. R., Cimpeanu, C., Meno Garcia, D., Kinross, J., Boshier, P., Mason, 
S., Bolt, F., Holmes, A. H. & Barklay, W. (2020) Investigating SARS-CoV-2 surface and air 
contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in 
London. medRxiv, 2020.05.24.20110346. 
 
 . CC-BY-NC-ND 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted June 26, 2020. .https://doi.org/10.1101/2020.06.24.20139501doi: medRxiv preprint 
